May 11, 2022 4:10 pm EDT VolitionRx Limited Announces First Quarter 2022 Financial Results and Business Update
May 6, 2022 8:00 am EDT VolitionRx Limited Schedules First Quarter 2022 Earnings Conference Call and Business Update
Apr 25, 2022 8:00 am EDT Volition Launches its Nu.Q® Vet Cancer Test in Asia Through its Appointed Distributor SAGE Healthcare
Apr 6, 2022 8:00 am EDT Volition appoints Sharon Ballesteros as U.S. Head of Quality and Development Process
Mar 30, 2022 4:10 pm EDT VolitionRx Limited Announces Full Fiscal Year 2021 Financial Results and Business Update
Mar 29, 2022 8:00 am EDT Volition Signs Exclusive $28 million License and Supply Agreement with Heska Corporation to Distribute Nu.Q® Vet Cancer Screening Test at the Point of Care
Mar 28, 2022 4:25 pm EDT VolitionRx Limited Schedules Full Fiscal Year 2021 Earnings Conference Call and Business Update
Jan 20, 2022 8:30 am EST Volition presents study data at ASCO GI 2022 on circulating nucleosomes for the detection of colorectal cancer and high-risk advanced adenomas
